US FDA clears first blood test to detect Alzheimer's disease
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
The U.S. Food and Drug Administration said on Friday it had cleared Fujirebio Diagnostics ' blood test to diagnose Alzheimer's disease , making the test the first of its kind to detect the condition.The blood test, branded as Lumipulse, will initially likely be used to rule out Alzheimer's, with positive results signaling the need for more advanced diagnostics.Alzheimer's, which gradually destroys memory and thinking skills, is characterized by certain changes in the brain, including a buildup of amyloid beta plaques that result in loss of neurons responsible for transmitting information.Fujirebio's device measures two specific proteins in the blood, pTau217 and β-amyloid 1-42, and calculates a ratio between them.This ratio is linked to the presence of amyloid plaques in the brain, which is a key sign of Alzheimer's.Detecting these plaques usually requires a PET brain scan or a spinal tap, which is a more invasive procedure to collect fluid from the spine.Lumipulse only needs a blood draw, making it much easier and more comfortable for patients, the FDA said."Alzheimer's disease impacts too many people, more than breast cancer and prostate cancer combined," said FDA Commissioner Martin Makary."Knowing that 10% of people aged 65 and older have Alzheimer's and that by 2050 that number is expected to double, I am hopeful that new medical products such as this one will help patients."Lumipulse and C2N Diagnostics' PrecivityAD2 were the top two performers when compared with four other commercial blood tests for Alzheimer's, according to a study led by researchers at Washington University School of Medicine.The FDA has approved Biogen and partner Eisai's Leqembi and Eli Lilly's Kisunla for the treatment of this disease. (Reporting by Christy Santhosh in Bengaluru; Editing by Shreya Biswas and Shailesh Kuber)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
FDA butter recall: Over 64,000 pounds of butter recalled due to ‘life-threatening' milk allergen risk, warning issued
The US Food and Drug Administration (FDA) has raised the alert level on a major butter recall involving 64,800 pounds of Bunge North America Inc.'s NH European Style Butter Blend, citing the undeclared presence of milk, a known major allergen that poses potentially life‑threatening risks to consumers with milk allergies. Recall details and timeline The recall was voluntarily initiated on July 14 by Bunge North America Inc., headquartered in Chesterfield, Missouri, due to a failure to declare milk on the ingredient label. The FDA elevated the recall to a Class II classification, its second‑highest alert level, on July 30, signaling that exposure may cause temporary or medically reversible adverse health effects, with only a remote chance of serious harm. What has been recalled Affected product: NH European Style Butter Blend in one‑pound blocks. Lot code: 5064036503. Packaging: white paperboard cases containing 36 blocks per case; total of about 1,800 cases, equating to approximately 64,800 lbs. Distribution: 12 centers across the US and one center in the Dominican Republic. As of early August, no confirmed illnesses or hospitalizations have been reported in connection with the recall. Risk from milk allergens Consuming milk allergens can lead to a range of reactions, from mild digestive issues to severe, life-threatening anaphylactic shock. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Mix 3 Kitchen Ingredients, Wake Up Thinner Every Morning Get Fit Today Click Here Undo Common symptoms include hives, vomiting, stomach cramps, and diarrhea. In some cases, milk allergy can trigger anaphylaxis, which requires immediate medical attention. Here's a detailed breakdown: Allergic reactions: Milk allergy is a common food allergy, particularly in children. It involves the immune system mistakenly identifying milk proteins (like casein and whey) as harmful and launching an attack. This can result in various symptoms: Mild to moderate: Hives, itching, vomiting, diarrhea, stomach cramps, and skin rashes. Severe: Anaphylaxis, a potentially fatal reaction characterized by difficulty breathing, wheezing, throat swelling, dizziness, and a drop in blood pressure. Lactose intolerance: Many individuals lack sufficient lactase, the enzyme needed to break down lactose, the sugar found in milk. This can lead to: Digestive issues: Abdominal cramps, bloating, diarrhea, and gas. Other potential issues: Skin problems: Some studies suggest dairy consumption can exacerbate acne and other skin conditions. Hormonal influence: Dairy cows are sometimes given hormones, which may have an impact on the human endocrine system. Notably, the severity of reactions to milk allergens can differ significantly from person to person, and while many children outgrow milk allergy, some may need to avoid milk products throughout their lives. FDA regulations Milk is one of the nine major allergens defined by US law, alongside eggs, peanuts, tree nuts, soybeans, wheat, fish, shellfish, and sesame. The FDA enforces strict labeling requirements under the Food Allergen Labeling and Consumer Protection Act (FALCPA), and milk remains the most frequent factor behind undeclared allergen recalls in dairy and processed foods. Undeclared milk can provoke reactions ranging from mild itchy hives, vomiting, or lip swelling to anaphylaxis, a severe, life‑threatening immune response that demands immediate medical attention. Consumer recommendations Consumers who purchased NH European Style Butter Blend with lot code 5064036503 are urged to stop consuming the product immediately. Those with a known milk allergy or sensitivity should look for the product in their homes and discard it or return it for a refund. If allergic symptoms occur, such as swelling of the face, throat tightness, difficulty breathing, hives, vomiting, or dizziness, consumers are urged to seek medical care immediately and use emergency medication like epinephrine if prescribed. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
Hindustan Times
5 hours ago
- Hindustan Times
FDA recalls 60,000+ pounds of butter over undeclared, ‘life-threatening' milk allergens
Bunge North America Inc, based in Missouri, has voluntarily recalled 64,800 pounds of its NH European Style Butter Blend after it was found to contain undeclared milk, a major food allergen. The US Food and Drug Administration (FDA) issued a Class II risk classification for the recall on July 30, following its initiation on July 14, as per USA Today. Over 60,000 pounds of butter were recalled by the FDA across US.(Shutterstock) This recall affects 1,800 cases of the product, each containing 36 blocks of butter blend packaged in white paperboard cases, reported Newsweek. It added that the product was distributed to 12 centers across the United States and one in the Dominican Republic. Why the recall matters According to Newsweek, milk is one of the nine major allergens that must be declared on food labels under US law. Failure to disclose milk content can result in severe allergic reactions, including anaphylaxis, especially in children and those with milk allergies. The FDA's Class II classification indicates that the product could lead to temporary or medically reversible health consequences, although the risk of severe or life-threatening outcomes is considered remote. Also read: Meet baby 'Kelce Taylor': Missouri couple names newborn after Taylor Swift and Travis Kelce Product details Name: NH European Style Butter Blend Manufacturer: Bunger Oils, Chesterfield, MO Net weight per block: 1 pound Total recalled: 64,800 pounds Packaging: 36 blocks per white paperboard case UPC Code: 1 00 78684 73961 2 Lot Code: 5064036503 The particular butter blend is believed to be used primarily by food manufacturers, rather than sold directly to consumers. Expert warnings and allergic risk Another report in The Healthy Reader's Digest cited that milk allergies were among the most common in children, with potential symptoms ranging from vomiting and hives to life-threatening respiratory issues. Dr Sebastian Lighvani, a New York-based allergist, told Newsweek, 'Every three minutes in the US, someone lands in the emergency room due to food-related allergic reactions.' With estimates suggesting that 6.2 million Americans may have milk allergy, the omission of allergen information poses a significant risk. More on Bunge North America According to another USA Today report, Bunge North America is based in Chesterfield, Missouri, and is an agribusiness that produces and markets multiple food ingredients, including corn, wheat, rice, soybeans, and feed peas. FAQs Q1: What is the recalled product? A: NH European Style Butter Blend by Bunge North America, packaged in 1-pound blocks. Q2: Why is it being recalled? A: The product contains undeclared milk, posing a health risk to individuals with milk allergies. Q3: What does a Class II FDA recall mean? A: It means the product may cause temporary or medically reversible harm, though serious health risks are unlikely. Q4: Where was the product distributed? A: To 12 distribution centres in the U.S. and one in the Dominican Republic. Q5: Was the product sold directly to consumers? A: It appears to be intended for use by food manufacturers, not direct retail sale.
Mint
5 hours ago
- Mint
FDA recalls over 64,000 pounds of butter over milk allergen risk; warning issued for adverse health consequences
The U.S. Food and Drug Administration (FDA) has issued a recall for more than 64,000 pounds of butter, citing concerns over undeclared milk allergens that could cause adverse health effects in consumers. According to a July 14 alert, Bunge North America, a food ingredient company based in Chesterfield, Missouri, voluntarily recalled 1,800 cases of its NH European Style Butter Blend. The affected butter was distributed across 12 centres in the United States and one in the Dominican Republic. On July 31, the FDA classified the recall under its Class II risk category—the agency's second-highest warning level—stating that 'consumption could pose temporary or medically reversible adverse health consequences.' The issue lies in the product's labelling, which failed to declare the presence of milk, a known allergen that can cause reactions in sensitive individuals. No injuries or illnesses have yet been reported in connection with the recall. USA TODAY has reached out to Bunge North America for comment regarding the oversight and recall procedures but has not yet received a response. Bunge North America is a major player in the agribusiness and food ingredient sector, producing and distributing items such as corn, wheat, rice, soybeans, and feed peas, alongside cooking ingredients like butter blends. Consumers who may have purchased the affected product are advised to check for the NH European Style Butter Blend and discontinue use immediately if any undeclared allergen risks apply. The FDA urges consumers with milk allergies or sensitivities to exercise caution and monitor product recall alerts closely.
